CSI Market
Sign In | Register

Viracta Therapeutics Inc (VIRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VIRX Annual Balance Sheets →
The balance sheet data below highlights changes in Viracta Therapeutics Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent13.13
Short-term Investments, Total8.01
Cash & Short-term Investments21.00
Prepaid Expense And Other Assets Current0.67
Total Current Assets21.80
Equipment/Property/Plant Net0.11
Other Assets, Noncurrent0.04
Operating Lease Right Of Use Asset-
Total Assets21.96
Liabilities
Accounts Payable, Current AC1.82
Accrued Liabilities, Current AC9.85
Debt, Current LI16.91
Other Liabilities, Current0.00
Total Current Liabilities28.58
Other Long-term Debt, Current OT0.00
Total Long-term Debt0.00
Operating Lease Liability Current-
Total Liabilities28.58
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock288.83
Retained Earnings / Accumulated Deficit-295.46
Other Equity0.01
Common Stockholder's Equity-6.62
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-6.62
Liabilities & Stockholder's Equity21.96
4 historic quarters locked

Sign in to unlock the full Viracta Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Viracta Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 13, 2024
  • Source: virx-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-126385

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.